Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Edward D. Esplin
Points to Consider: Is There Evidence to Support BRCA1/2 and Other Inherited Breast Cancer Genetic Testing for All Breast Cancer Patients? A Statement of the American College of Medical Genetics and Genomics (ACMG)
Genetics in Medicine
Medicine
Genetics
Possible Precision Medicine Implications From Genetic Testing Using Combined Detection of Sequence and Intragenic Copy Number Variants in a Large Cohort With Childhood Epilepsy
Epilepsia Open
Neurology
Related publications
The Use of ACMG Secondary Findings Recommendations for General Population Screening: A Policy Statement of the American College of Medical Genetics and Genomics (ACMG)
Genetics in Medicine
Medicine
Genetics
Women's Receptivity to Testing for a Genetic Susceptibility to Breast Cancer.
American Journal of Public Health
Environmental
Public Health
Occupational Health
Lurbinectedin Is Active in Patients With BRCA1/2 Mutant Breast Cancer
Cancer Discovery
Oncology
Polygenic Inherited Predisposition to Breast Cancer
Cold Spring Harbor Symposia on Quantitative Biology
Biochemistry
Genetics
Molecular Biology
A Prior Diagnosis of Breast Cancer Is a Risk Factor for Breast Cancer in BRCA1 and BRCA2 Carriers
Current Oncology
Oncology
Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer From the American Society of Breast Surgeons
Annals of Surgical Oncology
Oncology
Surgery
Noninvasive Prenatal Screening for Fetal Aneuploidy, 2016 Update: A Position Statement of the American College of Medical Genetics and Genomics
Genetics in Medicine
Medicine
Genetics
Venous Thromboembolism Laboratory Testing (Factor v Leiden and Factor II C.*97G>A), 2018 Update: A Technical Standard of the American College of Medical Genetics and Genomics (ACMG)
Genetics in Medicine
Medicine
Genetics
What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?
Archives of Breast Cancer
